Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tyler L. Harris"'
Autor:
William T. Barker, Tyler L. Harris, Courtney E. Chandler, Christian Melander, Sara E. Martin, T. Vu Nguyen, Robert K. Ernst, Yohei Doi, Roberta J. Melander, Christopher Goodell
Publikováno v:
Bioorganicmedicinal chemistry. 25(20)
Bacterial resistance to polymyxin antibiotics has taken on a new and more menacing form. Common are genomically-encoded resistance mechanisms to polymyxins, specifically colistin (polymyxin E), however, the plasmid-borne mobile colistin resistance-1
Publikováno v:
ACS infectious diseases. 1(5)
The anthelmintic closantel has shown promise in abrogating the L3 molting of Onchocerca volvulus, the causative agent of the infectious disease onchocerciasis. In our search for alternative scaffolds, we utilized a fragment replacement/modification a
Autor:
Cody J. Wenthur, Grahame Mackenzie, Kim D. Janda, Tyler L. Harris, Alberto Diego-Taboada, T. S. Corbitt
Publikováno v:
Chem Commun (Camb)
3,4-Diaminopyridine has shown promise in reversing botulinum intoxication, but poor pharmacokinetics and a narrow therapeutic window limit its clinical utility. Thus, we developed a pH-dependent oral delivery platform using club moss spore exines. Th
Autor:
Kyoji Tsuchikama, Tyler L. Harris, Gunnar F. Kaufmann, Jie Zhu, Major Gooyit, Kim D. Janda, Daniel Globisch
Publikováno v:
Angewandte Chemie (International ed. in English). 55(12)
Reported herein is that (4S)-4,5-dihydroxy-2,3-pentanedione (DPD) can undergo a previously undocumented non-enzymatic glycation reaction. Incubation of DPD with viral DNA or the antibiotic gramicidin S resulted in significant biochemical alterations.
Autor:
Tyler L. Harris, Xiaoqing Cai, Malcolm R. Wood, Major Gooyit, Matthew Lardy, Jie Zhu, Kim D. Janda
Publikováno v:
Chemistrybiology. 22(4)
Summary The emergence of antibiotic resistance places a sense of urgency on the development of alternative antibacterial strategies, of which targeting virulence factors has been regarded as a "second generation" antibiotic approach. In the case of P
Autor:
David M. Margolis, Noelle P. Dahl, Daniel L. Feldheim, Candice A. Smith, Erick A. Lindsey, Daniel C. Whitehead, Jamee Bresee, Carrie A. Simpson, Christian Melander, Tyler L. Harris, Carolina Garrido, Carly J. Carter
Background: Antiretroviral therapy (ART) has improved lifespan and quality of life of patients infected with the HIV-1. However, ART has several potential limitations, including the development of drug resistance and suboptimal penetration to selecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cdb2970a07be3f461e85ee15df3dd1
Botulinum neurotoxicity is characterized by peripheral neuromuscular blockade/flaccid paralysis that can lead to respiratory failure and ultimately death. Current therapeutic options provide relief in a pre-exposure scenario, but there are no clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a02cb9592dea67f4f32582cdec42cdc
https://europepmc.org/articles/PMC4140587/
https://europepmc.org/articles/PMC4140587/
Autor:
Andrew A. Yeagley, Rui Su, Tyler L. Harris, Christian Melander, Lingling Peng, Robert K. Ernst, Roberta J. Worthington, Robert E. Furlani, Kara McColough, Christopher Bracket, Zhaoming Su
New approaches are required to control multi-drug resistant (MDR) bacterial infections in military medical facilities, as injured Warfighters are highly susceptible to such infections. 2-Aminoimidazole compounds that, at low micromolar levels and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ad78c1f522eb705cadc167a8a8b728
https://doi.org/10.21236/ada599268
https://doi.org/10.21236/ada599268
Autor:
Daniel V. Zurawski, Tyler L. Harris, Lauren E. Hittle, Roberta J. Worthington, Robert K. Ernst, Christian Melander
Publikováno v:
ACS chemical biology. 9(1)
Infections caused by multi-drug resistant bacteria, particularly Gram-negative bacteria, are an ever-increasing problem. While the development of new antibiotics remains one option in the fight against bacteria that have become resistant to currently
Publikováno v:
Angewandte Chemie (International ed. in English). 51(45)
The use of adjuvant molecules that have the ability to restore the susceptibility of multi-drug resistant bacteria, such as MRSA, to clinically available antibiotics is a promising alternative to the development of novel antimicrobials. We report an